A Key Cannabis Event Launching 2026 The Grow Up Conference & Expo Vancouver 2026 is rapidly shaping up as one of the most important cannabis events of the year for industry professionals, innovators, and entrepreneurs. Set for January 19–21, 2026, at the Vancouver Convention Centre (East Building) in British Columbia, this premier conference and tradeContinue reading “Grow Up Vancouver 2026 Set to Unite Cannabis Leaders at Major Industry Conference”
Category Archives: Cannabis Business
Stay informed on cannabis business developments shaping licensed operators, multi-state brands, and emerging companies across the legal marijuana industry. This category covers the strategies, challenges, and market trends affecting one of the fastest-growing regulated sectors in the global economy.
From dispensary expansion and licensing strategy to mergers and acquisitions, capital investment, and retail positioning, Cannabis Business coverage examines how companies launch, scale, and compete in complex regulatory environments. As legalization expands and markets mature, businesses must adapt to shifting compliance requirements, tax structures, supply chain pressures, and evolving consumer demand.
What This Category Covers
Within Cannabis Business, readers will find analysis and reporting on:
Dispensary expansion and multi-state operator growth
Mergers, acquisitions, and cannabis industry investment
Licensing strategy and regulatory compliance challenges
Retail trends and consumer purchasing behavior
Brand positioning and product diversification
Financial performance insights and market outlook analysis
As legalization spreads and competition intensifies, this section highlights the business strategies shaping the next phase of cannabis industry development.
Latest Cannabis Business Updates
↓
Eugene Dispensaries Mixed on Federal Cannabis Reclassification, Call for Full Legalization
Local Businesses Respond to Federal Policy Shift Eugene, Oregon cannabis dispensary managers are offering mixed reactions to the possibility of marijuana being reclassified from a Schedule I to a Schedule III controlled substance, a federal policy change currently under consideration by national authorities. While federal officials have suggested the move could acknowledge cannabis’ medical usageContinue reading “Eugene Dispensaries Mixed on Federal Cannabis Reclassification, Call for Full Legalization”
U.S. Cannabis Industry Shows Resilience as Market Faces New Business Dynamics
Market Growth Continues Despite Labor Shifts The U.S. legalized cannabis industry posted strong retail sales growth in 2025, even as employment dipped modestly, according to the 2025 Vangst Jobs Report, a comprehensive analysis released this year. The report shows the industry generated roughly $30.1 billion in legal retail sales — a 4.5% increase year-over-year —Continue reading “U.S. Cannabis Industry Shows Resilience as Market Faces New Business Dynamics”